[Research progress on the relationship between TRAF6 and neurodegenerative diseases]
Rui-Chang Luo1,2, Xin-Yi Wu1,2, Wen-Wen Yu3
1Zhejiang Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Sheng Li Xue Bao : [Acta Physiologica Sinica]
|August 28, 2024
Summary
Tumor necrosis factor receptor-associated factor 6 (TRAF6) plays a key role in neuroinflammation and neurodegenerative diseases (NDDs). Its ubiquitination mechanism is crucial for regulating NDDs like Alzheimer's and Parkinson's disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Global aging populations are increasing the prevalence of neurodegenerative diseases (NDDs).
- Neuroinflammation is a critical pathological feature of NDDs.
- Tumor necrosis factor receptor-associated factor 6 (TRAF6) is implicated in neuroinflammation and NDD development.
Purpose of the Study:
- To analyze the molecular structure, biological function, and ubiquitination of TRAF6.
- To summarize the relationship between TRAF6 and common NDDs.
- To elucidate the molecular mechanisms of TRAF6 in NDD pathogenesis.
Main Methods:
- Literature review and analysis of existing research on TRAF6.
- Examination of TRAF6's role in neuroinflammation.
- Investigation of TRAF6 ubiquitination pathways.
Main Results:
- TRAF6's molecular structure and biological functions were detailed.
- The critical role of TRAF6 ubiquitination in regulating neuroinflammation was highlighted.
- TRAF6's involvement in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and ALS was analyzed.
Conclusions:
- TRAF6 is a significant regulator in the pathogenesis of various NDDs.
- Understanding TRAF6 ubiquitination provides insights into NDD mechanisms.
- This research offers a theoretical basis for developing NDD treatments targeting TRAF6.
